SG Americas Securities’s VivoSim Labs VIVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-79
Closed -$10K 3254
2019
Q2
$10K Sell
79
-716
-90% -$135K ﹤0.01% 3009
2019
Q1
$189K Buy
795
+473
+147% +$119K ﹤0.01% 2615
2018
Q4
$74K Buy
322
+150
+87% +$37.8K ﹤0.01% 2774
2018
Q3
$48K Buy
+172
New +$51.7K ﹤0.01% 2967
2017
Q4
Sell
-80
Closed -$43K 3705
2017
Q3
$43K Buy
80
+37
+86% +$19.7K ﹤0.01% 3338
2017
Q2
$27K Buy
+43
New +$28.9K ﹤0.01% 3073
2017
Q1
Sell
-174
Closed -$141K 3605
2016
Q4
$141K Buy
174
+28
+19% +$22.2K ﹤0.01% 2619
2016
Q3
$132K Buy
146
+62
+74% +$60.7K ﹤0.01% 2840
2016
Q2
$75K Sell
84
-173
-67% -$116K ﹤0.01% 2429
2016
Q1
$134K Buy
257
+92
+56% +$46.8K ﹤0.01% 2450
2015
Q4
$98K Sell
165
-828
-83% -$600K ﹤0.01% 2402
2015
Q3
$165K Buy
993
+794
+399% +$603K ﹤0.01% 1569
2015
Q2
$180K Buy
+199
New +$223K ﹤0.01% 2030

Other funds holding VIVS

SG Americas Securities's VIVS Position: Q3 2019 in Review

SG Americas Securities sold out of VivoSim Labs (VIVS) in Q3 2019, closing a stake of 79 shares — an estimated $10K sold.

SG Americas Securities first reported a position in VIVS in Q2 2015 and held it in 13 quarters. The position peaked at $189K in Q1 2019. 78 funds tracked by Wall St. Rank hold VIVS as of Q3 2019.

  • SG Americas Securities reported no remaining VivoSim Labs position as of Q3 2019 after selling out during the quarter.
  • SG Americas Securities sold 79 VivoSim Labs shares in Q3 2019, an estimated $10K.
  • SG Americas Securities first reported a position in VivoSim Labs in Q2 2015 and held it in 13 quarters.
  • SG Americas Securities's VivoSim Labs position peaked at $189K in Q1 2019.
  • 78 funds tracked by Wall St. Rank held VivoSim Labs as of Q3 2019.

Based on SG Americas Securities's 13F filing for Q3 2019, filed 4 Nov 2019.